Acute and Long-Term Healthcare Utilization and Expenditures for Serious Bacterial Infections among Newborns in US Hospitals
Serious bacterial infections among newborns place a substantial burden on the US healthcare system for the treatment of acute illness as well as long-term complications. Interventions targeting the prevention of newborn bacterial infections have the potential to yield significant resource utilization and cost offsets.
Authors
- Kristen N. Noble (ORCID: https://orcid.org/0000-0003-3396-3172)
- Kyla Hayford (ORCID: https://orcid.org/0000-0002-9872-2313)
- Derek Weycker (ORCID: https://orcid.org/0000-0002-5405-2215)
- Jennifer C. Moïsi (ORCID: https://orcid.org/0000-0002-7137-5630)
- Sarah J Willis
- Lisa Abramovitz
- Katharina Schley (ORCID: https://orcid.org/0000-0002-0975-4154)
Institutions
- Indiana University Health (US)
- Pfizer (United States) (US)
- Pfizer (Germany) (DE)
- Prevea Health (US)
- Pfizer (France) (FR)
- Indiana University – Purdue University Indianapolis (US)
Publication Details
- Journal
- Infectious Diseases and Therapy
- Published
- 2025-11-27
- DOI
- https://doi.org/10.1007/s40121-025-01271-7
- Primary Topic
- Neonatal and Maternal Infections
- Type
- article
- Field-Weighted Citation Impact
- 0.00